19:57 , Oct 18, 2018 |  BC Extra  |  Company News

Management tracks: Autolus, Bayer, Cambridge Allergy

T cell cancer therapy company Autolus Therapeutics plc (NASDAQ:AUTL) hired Adam Hacker as SVP for regulatory affairs and quality, a newly created position. Previously, he was VP, head of vaccines and scientific innovation projects, global...
21:09 , Jul 16, 2018 |  BC Extra  |  Company News

Management tracks: Cerecor, Sangamo

Neurology play Cerecor Inc. (NASDAQ:CERC) said CFO Mariam Morris is stepping down. She is succeeded by Joe Miller, who was VP of finance at Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Additionally, Cerecor hired...
01:11 , Jul 15, 2017 |  BC Extra  |  Company News

Management tracks

Immunotherapy company Advaxis Inc. (NASDAQ:ADXS) said President and CEO Daniel O’Connor resigned. CBO Anthony Lombardo will be interim CEO while the company seeks a replacement. Rare disease company OxThera AB (Stockholm, Sweden) named Matthew Gantz...
20:23 , May 22, 2017 |  BC Extra  |  Financial News

Sofinnova Partners promotes Seghezzi

Sofinnova Partners promoted Graziano Seghezzi to managing partner from partner. Seghezzi rejoined Sofinnova in 2006 following a stint at Index Ventures . He holds board seats at several of the firm's portfolio companies, including cardiovascular...
18:58 , Mar 10, 2017 |  BioCentury  |  Finance

Second wind

Gimv and Sofinnova Partners are backing Breath Therapeutics Holding B.V. with one of the largest European series A rounds in the past 10 years because they believe the company has solved the issues that prevented...
00:37 , Mar 10, 2017 |  BC Week In Review  |  Financial News

Breath Therapeutics completes venture financing

On March 8, respiratory disease company Breath Therapeutics Holding B.V. (Munich, Germany) raised €43.5 million ($46.2 million) in a series A round co-led by Gimv and Sofinnova Partners . Gilde Healthcare also participated. Breath Therapeutics...
18:55 , Mar 8, 2017 |  BC Extra  |  Financial News

Pari spinout Breath raises €43.5M series A

Respiratory disease company Breath Therapeutics Holding B.V. (Munich, Germany) debuted with a €43.5 million ($46.2 million) series A round co-led by Gimv and Sofinnova Partners , with Gilde Healthcare also participating. Spun out of Pari...